| European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa CC Zouboulis, N Desai, L Emtestam, RE Hunger, D Ioannides, I Juhász, ... Journal of the European Academy of Dermatology and Venereology 29 (4), 619-644, 2015 | 1108 | 2015 |
| Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ... Annals of internal medicine 157 (12), 846-855, 2012 | 505 | 2012 |
| Elevated levels of tumour necrosis factor (TNF)‐á, interleukin (IL)‐1â and IL‐10 in hidradenitis suppurativa skin: a rationale for targeting TNF‐á and IL‐1â HH Van der Zee, L de Ruiter, DG Van Den Broecke, WA Dik, JD Laman, ... British Journal of Dermatology 164 (6), 1292-1298, 2011 | 490 | 2011 |
| Diagnostic delay in hidradenitis suppurativa is a global problem DM Saunte, J Boer, A Stratigos, JC Szepietowski, I Hamzavi, KH Kim, ... British journal of dermatology 173 (6), 1546-1549, 2015 | 376 | 2015 |
| Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity CC Zouboulis, T Tzellos, A Kyrgidis, GBE Jemec, FG Bechara, ... British Journal of Dermatology 177 (5), 1401-1409, 2017 | 364 | 2017 |
| Depression in patients with hidradenitis suppurativa AJ Onderdijk, HH Van der Zee, S Esmann, S Lophaven, DN Dufour, ... Journal of the European Academy of Dermatology and Venereology 27 (4), 473-478, 2013 | 299 | 2013 |
| Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions HH van der Zee, EP Prens, J Boer Journal of the American Academy of Dermatology 63 (3), 475-480, 2010 | 259 | 2010 |
| Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments HH van der Zee, JD Laman, J Boer, EP Prens Experimental dermatology 21 (10), 735-739, 2012 | 256 | 2012 |
| Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity AMR Schrader, IE Deckers, HH van der Zee, J Boer, EP Prens Journal of the American Academy of Dermatology 71 (3), 460-467, 2014 | 253 | 2014 |
| The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa HH Van Der Zee, J Boer, EP Prens, GBE Jemec Dermatology 219 (2), 143-147, 2009 | 250 | 2009 |
| Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization–systematic review and recommendations from the HS ALLIANCE working group CC Zouboulis, FG Bechara, JL Dickinson‐Blok, W Gulliver, B Horváth, ... Journal of the European Academy of Dermatology and Venereology 33 (1), 19-31, 2019 | 233 | 2019 |
| New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes HH van der Zee, GBE Jemec Journal of the American Academy of Dermatology 73 (5), S23-S26, 2015 | 197 | 2015 |
| Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study HH Van der Zee, CJ Van Der Woude, EF Florencia, EP Prens British Journal of Dermatology 162 (1), 195-197, 2010 | 197 | 2010 |
| Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project A Garg, E Neuren, D Cha, JS Kirby, JR Ingram, GBE Jemec, S Esmann, ... Journal of the American Academy of Dermatology 82 (2), 366-376, 2020 | 191 | 2020 |
| Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model ARJV Vossen, HH Van der Zee, EP Prens Frontiers in immunology 9, 427601, 2018 | 177 | 2018 |
| Adalimumab (antitumour necrosis factor‐á) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study HH Van der Zee, JD Laman, L de Ruiter, WA Dik, EP Prens British Journal of Dermatology 166 (2), 298-305, 2012 | 165 | 2012 |
| Alterations in leucocyte subsets and histomorphology in normal‐appearing perilesional skin and early and chronic hidradenitis suppurativa lesions HH Van der Zee, L De Ruiter, J Boer, DG Van Den Broecke, ... British Journal of Dermatology 166 (1), 98-106, 2012 | 163 | 2012 |
| Pathogenesis and pharmacotherapy of Hidradenitis suppurativa M Nazary, HH Van Der Zee, EP Prens, G Folkerts, J Boer European journal of pharmacology 672 (1-3), 1-8, 2011 | 159 | 2011 |
| Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement IE Deckers, HH van der Zee, J Boer, EP Prens Journal of the American Academy of Dermatology 72 (3), 485-488, 2015 | 125 | 2015 |
| Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross‐sectional study IC Janse, IE Deckers, AD van Der Maten, AWM Evers, J Boer, ... British Journal of Dermatology 176 (4), 1042-1047, 2017 | 124 | 2017 |
Gregor JemecUniversity of CopenhagenVerified email at regionsjaelland.dk
